Torrent Pharmaceuticals Limited (BOM:500420)
India · Delayed Price · Currency is INR | Market Cap | 1.21T |
| Revenue (ttm) | 118.35B |
| Net Income (ttm) | 20.02B |
| Shares Out | 338.45M |
| EPS (ttm) | 59.15 |
| PE Ratio | 60.39 |
| Forward PE | 45.49 |
| Dividend | 32.00 (0.89%) |
| Ex-Dividend Date | Jun 20, 2025 |
| Volume | 3,602 |
| Average Volume | 12,066 |
| Open | 3,600.00 |
| Previous Close | 3,596.85 |
| Day's Range | 3,561.80 - 3,604.40 |
| 52-Week Range | 2,891.45 - 3,790.00 |
| Beta | 0.13 |
| RSI | 54.24 |
| Earnings Date | Jul 28, 2025 |
About Splunk
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It als... [Read more]
Financial Performance
In 2024, Torrent Pharmaceuticals's revenue was 115.16 billion, an increase of 7.35% compared to the previous year's 107.28 billion. Earnings were 19.11 billion, an increase of 15.39%.
Financial StatementsNews
Torrent Pharma’s Vizag plant clears USFDA inspection with zero observations
Torrent Pharmaceuticals has announced the successful completion of a USFDA inspection at its manufacturing facility located in Visakhapatnam, Andhra Pradesh. The inspection was conducted between July ...
Torrent Pharma Q1 net profit rises 20% on broad-based growth
Torrent Pharmaceuticals reported a robust 20% increase in net profit, reaching Rs 548 crore for Q1 FY26, fueled by strong performances in India, the US, and Brazil. Consolidated revenue grew by 11% to...
Torrent Pharma shares jump 2% after Q1 profit jumps 20% YoY; US and India drive growth
Shares of Torrent Pharmaceuticals Ltd climbed nearly 2% to ₹3,695.40 on the NSE on Tuesday, after the company posted a 20% year-on-year increase in consolidated net profit to ₹548 crore for the June q...
Citi bullish on Torrent Pharma, sees 21% upside as margins hold strong and US recovery expected
Citi has maintained a Buy rating on Torrent Pharmaceuticals, raising its target price to ₹4,380, implying an upside of approximately 20.7% from the current market price of ₹3,630.00. The brokerage not...
Stocks to watch on July 29: Torrent Pharma, IndusInd Bank, GAIL, BEL, Radico Khaitan, IEX, United Spirits in focus after fresh brokerage calls
A fresh wave of brokerage reports has put the spotlight on several stocks that could see action on July 29. From upgrades to earnings commentary and new initiations, key developments have come in for ...
Torrent Pharmaceuticals to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore
Torrent Pharmaceuticals Limited has announced that it will acquire up to 2.41% of the equity share capital of JB Chemicals & Pharmaceuticals Limited (JB Chemicals) for a total consideration of approxi...
Stocks to watch on brokerages today, June 30: Uno Minda, Torrent Pharma, RBL Bank, Reliance Industries and more
Leading global brokerages have released updated views on several major Indian stocks, adjusting ratings and target prices based on recent developments and performance trends. Here’s a round-up of the ...
Torrent Pharmaceuticals shares rise over 3% today; Company announces Rs 300 crore commercial paper issuance
Shares of Torrent Pharmaceuticals surged over 3% during Friday’s session, following the company’s announcement of issuing commercial papers worth Rs 300 crore. The stock climbed 3.08% to trade at Rs 3...
Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results
Pharma stocks were trading firmly in the green on Tuesday morning, with GlaxoSmithKline Pharmaceuticals leading the charge—rising 7.4% to ₹2,992.80 as of 10:05 AM. The broader sector saw widespread bu...
Torrent Pharma shares jump 3% as Q4 EBITDA rises 9.2% YoY to Rs 964 crore
Torrent Pharmaceuticals shares jumped over 3% in morning trade following robust Q4FY24 earnings. As of 9:27 AM, the shares were trading 3.17% higher at Rs 3,344.20, The company reported a net profit o...
Torrent Pharma share price: Nomura sees 11% upside, maintains neutral after Q4 miss due to one-off
Nomura has maintained a neutral rating on Torrent Pharmaceuticals, with a target price of ₹3,580, suggesting a modest upside of nearly 11% from the current market price of ₹3,233.10. The brokerage fla...
Torrent Pharma share price: Nuvama expects 16% upside, cites India, US growth and semaglutide launches
Nuvama Institutional Equities has maintained its buy rating on Torrent Pharmaceuticals with a target price of ₹3,760, citing steady Q4 performance and strong growth prospects across geographies. While...
Aman Mehta to lead Torrent Pharma in generational transition
Ahmedabad: Passing the baton while powering ahead — Torrent Pharmaceuticals is entering a new chapter as Aman Mehta, next-gen scion of the Mehta famil.
Torrent Pharmaceuticals issues Rs 300 crore worth of commercial papers at 7.13% discount rate
Torrent Pharmaceuticals Limited has issued commercial papers worth Rs 300 crore on March 25, 2025, as part of its short-term funding plans. The instruments have a tenure of 90 days and are set to matu...
Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2025 Earnings Call Highlights: Strong India Growth ...
Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2025 Earnings Call Highlights: Strong India Growth and Strategic Challenges
Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Top Q3 Results Tomorrow, January 24: HPCL, JSW Steel, IndiGo, Torrent Pharma, Godrej Consumer Products, Shriram Finance and more
The earnings season continues to heat up as several major companies are set to report their Q3FY25 results tomorrow. Among the highlights, the key companies to keep an eye on include Torrent Pharmaceu...
Pharma stocks weekly roundup: Biocon leads with 9.08% gain, Torrent Pharma up 4.91%, Lupin dips 1.82%
The pharmaceutical sector experienced diverse movements during the week of November 25–29, 2024. Among the notable performers, Biocon Ltd led the gains with a significant surge of ₹30.35 (9.08%), clos...
Torrent Pharmaceuticals market cap rises Rs 3,450 crore
Torrent Pharmaceuticals saw its stock price rise by 3.19% to Rs 3,305.00 in today’s trading session. This price surge contributed to an increase of Rs 3,450 crore in the company’s market capitalizatio...
Torrent Pharma receives EIR from USFDA for Pithampur facility
Torrent Pharmaceuticals has announced that it has received an Establishment Inspection Report (EIR) from the USFDA for its manufacturing facility in Pithampur, Madhya Pradesh. The inspection, conducte...
Torrent Pharma shares rise nearly 3% after receiving EIR from USFDA
Shares of Torrent Pharmaceuticals climbed 2.54% to trade at ₹3,180.65 as of 12:16 PM on November 22. The surge comes after the company announced it has received an Establishment Inspection Report (EIR...
Torrent Pharma Block Deal: 1.04 crore shares or 3% equity worth Rs 3,230 crore change hands
Torrent Pharmaceuticals shares dropped 3.15% to ₹3,114.35 as of 9:19 am on the NSE after a significant large trade. Approximately 1.04 crore shares, equating to 3.1% of equity, exchanged hands at ₹3,1...
Stock to watch today: Torrent Pharma promoter to sell up to 2.9% stake via block deal: Report
Torrent Pharmaceuticals Ltd. is likely to be in focus today as promoter entity Torrent Investments has announced plans to sell up to a 2.9% stake in the company through a block deal. This information ...
Torrent Pharmaceuticals shares in focus as Q2 profit rises 17.4% to ₹453 crore
Torrent Pharmaceuticals has attracted attention after reporting a 17.4% increase in net profit for the second quarter, rising to ₹453 crore. The company’s revenue grew by 8.6%, reaching ₹2,889 crore, ...
Torrent counters faulty drug claim
Torrent Pharmaceuticals Limited strongly denies allegations regarding its Shelcal 500 product, claiming the seized sample is counterfeit and not produced by them. The company has implemented anti-coun...